Evidence map›Paper›PMID 27925198›Full record

ArticleJournal of cellular physiology2017

Cancer Cell Plasticity: Rapid Reversal of Chemosensitivity and Expression of Stemness Markers in Lung and Breast Cancer Tumorspheres.

Juan Sebastian Yakisich, Neelam Azad, Vivek Kaushik, Anand Krishnan V Iyer

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Emerging role of lipid metabolism alterations in Cancer stem cells.Journal of experimental & clinical cancer research : CR · 2018
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan Sebastian YakisichDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, Virginia.
Neelam AzadDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, Virginia.
Vivek KaushikDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, Virginia.
Anand Krishnan V IyerDepartment of Pharmaceutical Sciences, School of Pharmacy, Hampton University, Hampton, Virginia.

Funding

Anti-Tumorigenic Potential of Novel Digitoxin AnaloguesSC1CA173069 · NCI · HAMPTON UNIVERSITY · PI IYER, ANAND K. · 2012 to 2016
$1.3M
Impact of Oxidative Stress-Regulated Angiogenesis in Pulmonary FibrosisSC1HL112630 · NHLBI · HAMPTON UNIVERSITY · PI AZAD, NEELAM · 2011 to 2015
$1.3M
NCI NIH HHS SC1 CA173069NHLBI NIH HHS SC1 HL112630
6 · The paper itself

Abstract

In cancer cells, the reversible nature of the stemness status in terms of chemoresistance has been poorly characterized. In this study, we have simulated one cycle of environmental conditions to study such reversibility by first generating floating tumorspheres (FTs) from lung and breast cancer cells by culturing them in serum-free media without the addition of any external mitogenic stimulation, and subsequently (after 2 weeks) re-incubating them back in serum-containing media to simulate routine culture conditions (RCCs). We found that cancer cells are extremely plastic: cells grown under RCCs become multidrug-resistant when grown as FTs, but upon re-incubation under RCCs quickly re-attach and lose the acquired resistance. These phenotypic changes are accompanied by concomitant changes in the expression of key proteins associated with multiple pathways important for chemoresistance, survival, and stemness maintenance. Therefore, our strategy provides an excellent experimental model to study environmental factors that modulate the plasticity of cancer cells. J. Cell. Physiol. 232: 2280-2286, 2017. © 2016 Wiley Periodicals, Inc.

Indexed as

Drug Resistance, MultipleDrug Resistance, NeoplasmAntineoplastic AgentsBiomarkers, TumorBreast NeoplasmsCell AdhesionCell PlasticityCell ProliferationCulture Media, Serum-FreeDose-Response Relationship, DrugDown-RegulationEpidermal Growth FactorErbB ReceptorsFemaleHumansLung NeoplasmsAntineoplastic AgentsBiomarkers, TumorCulture Media, Serum-FreeEGFR protein, humanEpidermal Growth FactorErbB ReceptorsProtein Kinase Inhibitors

Identifiers

PMID27925198
PMCPMC5444977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.